(Q33504302)
Statements
Phase I clinical and pharmacokinetic study of carzelesin (U-80244) given daily for five consecutive days (English)
Wolff I
Bench K
Beijnen JH
Bruntsch U
de Jong J
Groot Y
van Tellingen O
Wanders J
1 October 1996